Are prescribing doctors sensitive to the price that their patients have to pay in the Spanish National Health System?

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  González Lápez Valcárcel, Beatriz ^a   Librero, Julián ^b,c   Sanfélix Gimeno, Gabriel ^b   Peirá, Salvador ^b  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b Centro Superior de Investigacián en Salud Pública CSISP   (Spain)

^c INSTITUTO ARAGONÉS DE CIENCIAS DE LA SALUD   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; CLASSIFICATION; CLINICAL PRACTICE; COMMUNITY CARE; COMPARATIVE STUDY; COST; DRUG COST; ECONOMICS; FEE; GENERAL PRACTITIONER; HEALTH CARE PLANNING; HUMAN; MENTAL DISEASE; PENSION; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH; REGRESSION ANALYSIS; SPAIN; STATISTICS; UTILIZATION REVIEW;

CARDIOVASCULAR DISEASES; COMMUNITY HEALTH SERVICES; DEDUCTIBLES AND COINSURANCE; DRUG COSTS; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MENTAL DISORDERS; NATIONAL HEALTH PROGRAMS; PENSIONS; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PRESCRIPTION FEES; PSYCHOTROPIC DRUGS; REGIONAL MEDICAL PROGRAMS; REGRESSION ANALYSIS; SPAIN;

EID: 84856294670     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-333     Document Type: Article

References (24)

1. Physician agency. McGuire T, Handbook of Health Economics Elsevier, Culyer A, Newhouse J, 2000 461 528
2. Moral hazard in physician prescription behaviour. Lundin D, J Health Econ 2000 19 639 62
3. Spain: a decentralised health system in constant flux. Martin-Moreno JM, Alonso P, Clavería A, Gorgojo L, Peirá S, BMJ 2009 338 1170
4. The financing and price regulation of drugs in the Spanish National Health System: changes and continuity [In Spanish]. Puig-Junoy J, Gac Sanit 2007 21 1 4
5. Population Analysis by Area of Health of Changes in Consumption, Price and Expenditure of Cardiovascular Drugs in Eight AutonomousCommunities, Spain, 2005 [In Spanish]. Sanfélix-Gimeno G, Peirá S, Librero J, Ausejo-Segura M, Suárez-Alemán C, Molina-Lápez T, et al. Rev Esp Salud Publica 2010 84 389 406
6. Variations in utilization and expenditure in psycholeptic and psychoanaleptic drugs in the National Health System [In Spanish]. Librero J, Sanfélix-Gimeno G, Grupo de Investigacián en Utilizacián de Medicamentos del Sistema Nacional de Salud (Grupo IUM-SNS), Farm Aten Primaria 2008 6 4 126 30
7. ATC Index with DDDs 2005 Oslo: WHO Collaborating Centre for Drug Statistics Methodology 2004
8. ATC Index with DDDs 2006 Oslo: WHO Collaborating Centre for Drug Statistics Methodology 2005
9. Multilevel analysis: an introduction to basic and advanced multilevel modeling. Snijders TAB, Bosker RJ, London, Thousand Oaks, Calif.: Sage Publications 1999
10. Physician awareness of drug cost: a systematic review. Allan GM, Lexchin J, Wiebe N, PLoS Med 2007 4 9 283
11. Analysis of opinions, attitudes and knowledge of physicians of health centers of Valencia concerning efficacy and efficiency of drug prescriptions [in Spanish]. Alastrué Loscos JI, Meneu de Guillerna R, Peirá Moreno S, Aten Primaria 1998 21 3 165 71
12. Experts' agency problems: evidence from the prescription drug market in Japan. Iizuka T, Rand J Econ 2007 38 844 62
13. Dutch GPs' perceptions: the influence of out-of-pocket costs on prescribing. Kasje WN, Timmer JW, Boendermaker PM, Haaijer-Ruskamp FM, Soc Sci Med 2002 55 1571 8 (Pubitemid 35286880)
14. Physicians' attitudes about prescribing and knowledge of the costs of common medications. Reichert S, Simon T, Halm EA, Arch Intern Med 2000 160 18 2799 803
15. Physicians' perceived knowledge of and responsibility for managing patients' out-of-pocket costs for prescription drugs. Shrank WH, Asch SM, Joseph GJ, Young HN, Ettner SL, Kholodenko Y, et al. Ann Pharmacother 2006 40 9 1534 40 (Pubitemid 44330197)
16. Physicians' perceptions of relevant prescription drug costs: do costs to the individual patient or to the population matter most? Shrank WH, Joseph GJ, Choudhry NK, Young HN, Ettner SL, Glassman P, et al. Am J Manag Care 2006 12 9 545 51 (Pubitemid 44412035)
17. Physician consideration of patients' out-of-pocket costs in making common clinical decisions. Pham HH, Alexander GC, O'Malley AS, Arch Intern Med 2007 167 7 663 8 (Pubitemid 46598458)
18. Physicians' opinions about responsibility for patient out-of-pocket costs and formulary prescribing in two Midwestern states. Khan S, Sylvester R, Scott D, Pitts B, J Manag Care Pharm 2008 14 8 780 9
19. Medication costs: the role physicians play with their senior patients. Beran MS, Laouri M, Suttorp M, Brook R, J Am Geriatr Soc 2007 55 1 102 7 (Pubitemid 46046235)
20. Patient-physician communication about out-of-pocket costs. Alexander GC, Casalino LP, Meltzer DO, JAMA 2003 290 7 953 8 (Pubitemid 37430470)
21. Physician strategies to reduce patients' out-of-pocket prescription costs. Alexander GC, Casalino LP, Meltzer DO, Arch Intern Med 2005 165 6 633 6 (Pubitemid 40393144)
22. Association of prescription abandonment with cost share for high-cost specialty pharmacy medications. Gleason PP, Starner CI, Gunderson BW, Schafer JA, Sarran HS, J Manag Care Pharm 2009 15 8 648 58
23. Pharmaceutical policies: effects of cap and co-payment on rational drug use. Austvoll-Dahlgren A, Aaserud M, Vist G, Ramsay C, Oxman AD, Sturm H, et al. Cochrane Database Syst Rev 2008 1 D007017
24. Better pharmaceutical price comparison studies are needed for meaningful evaluation of price-control policies. Value Health 2008 11 129 30